Two Sigma Securities’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-2,808
Closed -$340K 1835
2025
Q2
$340K Buy
+2,808
New +$316K 0.04% 601
2024
Q4
Sell
-1,783
Closed -$205K 2726
2024
Q3
$205K Sell
1,783
-2,557
-59% -$290K ﹤0.01% 2135
2024
Q2
$462K Buy
4,340
+65
+2% +$6.53K 0.01% 1611
2024
Q1
$414K Sell
4,275
-1,919
-31% -$197K ﹤0.01% 1713
2023
Q4
$625K Buy
+6,194
New +$598K 0.01% 1383
2023
Q1
Sell
-21,193
Closed -$1.92M 3074
2022
Q4
$1.92M Buy
21,193
+7,390
+54% +$622K 0.06% 426
2022
Q3
$1.05M Buy
13,803
+363
+3% +$30.1K 0.03% 608
2022
Q2
$1.14M Buy
+13,440
New +$1.18M 0.04% 478
2022
Q1
Sell
-5,489
Closed -$475K 2379
2021
Q4
$480K Buy
+5,489
New +$456K 0.02% 549
2019
Q4
Sell
-9,732
Closed -$873K 2555
2019
Q3
$846K Buy
+9,732
New +$874K 0.01% 950
2019
Q2
Sell
-18,516
Closed -$1.57M 2325
2019
Q1
$1.59M Buy
18,516
+249
+1% +$20K 0.01% 399
2018
Q4
$1.41M Buy
18,267
+444
+2% +$34.6K 0.02% 499
2018
Q3
$1.38M Sell
17,823
-13,772
-44% -$1.02M 0.01% 892
2018
Q2
$2.14M Sell
31,595
-115,721
-79% -$7.99M 0.01% 890
2018
Q1
$10.7M Buy
+147,316
New +$11.2M 0.06% 270
2017
Q3
Sell
-3,588
Closed -$268K 1135
2017
Q2
$268K Sell
3,588
-586
-14% -$41.5K 0.05% 404
2017
Q1
$278K Buy
+4,174
New +$278K 0.05% 413

Other funds holding NVS

Two Sigma Securities's NVS Position: Q3 2025 in Review

Two Sigma Securities sold out of Novartis (NVS) in Q3 2025, closing a stake of 2,808 shares — an estimated $340K sold.

Two Sigma Securities first reported a position in NVS in Q1 2017 and held it in 17 quarters. The position peaked at $10.7M in Q1 2018. 1,400 funds tracked by Wall St. Rank hold NVS as of Q3 2025.

  • Two Sigma Securities reported no remaining Novartis position as of Q3 2025 after selling out during the quarter.
  • Two Sigma Securities sold 2,808 Novartis shares in Q3 2025, an estimated $340K.
  • Two Sigma Securities first reported a position in Novartis in Q1 2017 and held it in 17 quarters.
  • Two Sigma Securities's Novartis position peaked at $10.7M in Q1 2018.
  • 1,400 funds tracked by Wall St. Rank held Novartis as of Q3 2025.

Based on Two Sigma Securities's 13F filing for Q3 2025, filed 14 Nov 2025.